Biocon’s S&P Global ESG Score improves to 69 for 2024 EP News Bureau Jan 28, 2025 Biocon’s subsidiary Biocon Biologics, which also participated independently in the assessment for the first time, reported an…
Strides Pharma debuts with an ESG rating of 76/100 in S&P Global’s CSA 2024 EP News Bureau Jan 22, 2025 Strides has secured a position in the 94th percentile among its peers in the DRG Global Pharmaceuticals industry
Dr Reddy’s Laboratories announces major recognitions in gender equality and sustainability EP News Bureau Feb 9, 2023 Included in Bloomberg Gender-Equality Index for sixth year in a row and S&P Global’s Sustainability Yearbook for the third…
